JPMorgan Chase & Co. Cuts Dyne Therapeutics (NASDAQ:DYN) Price Target to $17.00
Dyne Therapeutics (NASDAQ:DYN – Get Free Report) had its target price cut by equities research analysts at JPMorgan Chase & Co. from $18.00 to $17.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside […]
More Stories
Credit Cards, Savings Accounts, Money Market: Best of the Best
By Rodd Mann Consumers are using credit cards like never before, with credit card balances currently at an all-time high....
CDC Says Measles Cases Confirmed in 19 States This Year
By Jack Phillips Measles cases have risen across the United States, with cases reported in 19 states in 2025, according...
4th Missing US Soldier Found Dead in Lithuania
By Rachel Acenas The body of a fourth U.S. Army soldier who went missing during a training exercise in Lithuania...
Senate Judiciary Chair Introduces Bill to End Nationwide Injunctions
By Sam Dorman Senate Judiciary Chair Chuck Grassley (R-Iowa) introduced legislation on March 31 to prevent courts from issuing nationwide...
Maine Gets Final Warning on Males in Female Sports
By Naveen Athrappully The U.S. Department of Education issued a final warning to the state of Maine, telling it to...
Vanguard Group Inc. Grows Position in Crocs, Inc. (NASDAQ:CROX)
Vanguard Group Inc. boosted its stake in shares of Crocs, Inc. (NASDAQ:CROX – Free Report) by 0.9% during the fourth...